Medivir AB: Interim Report, 1 January-30 September 2012*

Published: Nov 20, 2012

HUDDINGE, Sweden--(BUSINESS WIRE)--Regulatory News: Medivir (STO:MVIR-B): Interim period, January-September 2012

Net turnover totalled SEK 399.5 million (SEK 566.8 m), of which non-recurrent payments comprised SEK 0.0 million (SEK 401.2 million), sales of pharmaceuticals, SEK 120.6 million (SEK 63.7 m), and sales via parallel imports, SEK 277.7 million (SEK 101.2 m).

Back to news